Cleared Traditional

K062501 - VALIDATE THYROID CALIBRATION VERIFICATION / LINEARITY TEST SET, MODEL 901

K062501 is an FDA 510(k) clearance for VALIDATE THYROID CALIBRATION VERIFICATI..., manufactured by Maine Standards Co.. The device is a Class 1 Chemistry device with product code JJX cleared through the Traditional 510(k) pathway after a 35-day FDA review.

K062501 · Maine Standards Co. · Chemistry device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 2006
Decision
35d
Days
Class 1
Risk

K062501 is an FDA 510(k) clearance for the VALIDATE THYROID CALIBRATION VERIFICATION / LINEARITY TEST SET, MODEL 901. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Maine Standards Co. (Windham, US). The FDA issued a Cleared decision on September 29, 2006 after a review of 35 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K062501

510(k) Number K062501 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 25, 2006
Decision Date September 29, 2006
Days to Decision 35 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
54d faster than avg
Panel avg: 89d · This submission: 35d
Pathway characteristics
Predicate-based equivalence.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 492
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K062501.
FASTPACK TOTAL PSA METHOD VERIFICATION KIT
K062957 · Qualigen, Inc. · Apr 2007
LIBERTY NORMAL GLUCOSE CONTROL SOLUTION, MODEL 2120045/ HIGH GLUCOSE CONTROL SOLUTION, MODEL 2120047
K063855 · Liberty Healthcare Group, Inc. · Feb 2007
PRECINORM CK-MB AND PRECIPATH CK-MB CONTROLS
K062972 · Roche Diagnostics Corp. · Oct 2006
DREW SCIENTIFIC GLYCATED HEMOGLOBIN FIVE LEVEL LINEARITY KIT
K060510 · Drew Scientific , Ltd. · Jun 2006
LIBERTY NORMAL GLUCOSE CONTROL SOLUTION
K060706 · Liberty Healthcare Group, Inc. · Apr 2006
HEMOGLOBIN ALC CONTROL
K060570 · Compass Bioscience · Apr 2006
K062501 · VALIDATE THYROID CALIBRATION VERIFICATION / LINEARITY TEST SET, MODEL 901
Download PDF FDA Summary Maine Standards Co.